Logo En IconLogo Mark IconIcelandic Intellectual Property Office

SPC306

Daratumumab, bortezomib, thalidomide og dexamethasone

  • Status:
    Umsókn
  • Application date:
    10.7.2020
  • Application published:
    15.8.2020
  • Max expiry date:
    25.9.2032
  • Medicine name:
    DARZALEX
  • Medicine for children:
    No

Timeline

Today
10.7.2020Application
15.8.2020Publication
25.9.2032Expires

Marketing license

    • Foreign authorization number:
      EU/1/16/1101/001-002
    • Date:
      20.1.2020

    Owner

    • Name:
      Genmab A/S
    • Address:
      Carl Jacobsens Vej 30, Valby DK

    Agent

    • Name:
      Tego ehf.
    • Address:
      Pósthólf 8129, 128 Reykjavík

    Patent

    Deadlines

    TypeDeadline until

    Type: Formgallafrestur, annar

    Deadline until: 22.06.2024

    Upload documents